LI-RADS v2018:利用钆塞酸二钠增强MRI的辅助征象提高小肝细胞癌(≤20 mm)的诊断效能
回顾性分析154例患者183个肝脏观察灶,评估LI-RADS辅助征象对钆塞酸二钠增强MRI诊断≤20 mm小肝癌的作用。限制性扩散、移行期和肝胆期低信号为独立显著辅助征象;将其作为新主要征象升级仅用主要征象归为LR-4的病灶,可提高敏感度(68.0%–69.1% vs 61.9%,均P<0.05)而不降低特异度。
要点
- 限制性扩散、移行期低信号和肝胆期低信号是独立显著的辅助征象。
- 将仅用主要征象归为LR-4的病灶按上述辅助征象升级为LR-5可提高敏感度。
- 升级后特异度与LI-RADS v2018无显著差异。
核心结论
- 独立显著的辅助征象可用于将仅用主要征象归为LR-4的观察灶升级为LR-5,从而提高小肝癌的诊断效能。
研究设计与样本
- 回顾性研究,纳入154例患者共183个肝脏观察灶,使用钆塞酸二钠增强MRI,以LI-RADS v2018主要征象及主要联合辅助征象分类,并通过 logistic 回归分析确定独立显著辅助征象。
关键影像表现/征象
- 限制性扩散、移行期低信号和肝胆期低信号为独立显著辅助征象。
诊断标准与关键数值
- mLI-RADS a、c、e、g、h、i(分别以确定或任意1、2、3个上述辅助征象作为新主要征象,将仅用主要征象归为LR-4的病灶升级为LR-5)敏感度分别为68.0%、69.1%、69.1%、69.1%、69.1%、68.0%,LI-RADS v2018为61.9%,均P<0.05。
- mLI-RADS a、c、e、g、h、i特异度分别为84.9%、86.0%、84.9%、83.7%、84.9%、87.2%,LI-RADS v2018为88.4%,均P>0.05。
- 以独立显著辅助征象升级主要联合辅助征象归类的LR-4结节(mLI-RADS b、d、f)时,敏感度提高但特异度降低(均P<0.05)。
临床应用与阅片要点
- 阅片时可关注限制性扩散、移行期低信号和肝胆期低信号,作为将仅用主要征象归为LR-4的病灶升级为LR-5的辅助征象。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the role of ancillary features (AFs) of Liver Imaging Reporting and Data System (LI-RADS) in the diagnostic performance of small HCC (≤ 20 mm) on gadoxetic acid-enhanced MRI.
METHODS: A total of 154 patients with 183 hepatic observations were analysed in this retrospective study. Observations were categorized using only major features (MFs) and combined MFs and AFs. Independently significant AFs were identified through logistic regression analysis, and upgraded LR-5 criteria were developed using these as new MFs. The diagnostic performance of the modified LI-RADS (mLI-RADS) was calculated and compared with that of LI-RADS v2018 using McNemar's test.
RESULTS: Restricted diffusion, transitional and hepatobiliary phase hypointensity were independently significant AFs. The mLI-RADS a, c, e, g, h and i (upgraded LR-4 lesions that were categorized using only MFs to LR-5 using a certain or any one, two, three of the above AFs as new MFs) yielded a significantly greater sensitivity than that of the LI-RADS v2018 (68.0%, 69.1%, 69.1%, 69.1%, 69.1%, 68.0% vs. 61.9%, all p < 0.05), whereas the specificities were not significantly different (84.9%, 86.0%, 84.9%, 83.7%, 84.9%, 87.2% vs. 88.4% all p > 0.05). When independently significant AFs were used to upgrade the LR-4 nodules categorized by combined MFs and AFs (mLI-RADS b, d and f), the sensitivities were improved, but the specificities were decreased (all p < 0.05).
CONCLUSIONS: Independently significant AFs may be used to upgrade an observation from LR-4 (categorized only using MFs) to LR-5, which can improve diagnostic performance for small HCC.
引用
- Lyu R, Hu W, Wang D, et al. LI-RADS v2018: utilizing ancillary features on gadoxetic acid-enhanced MRI to improve the diagnostic performance of small hapatocellular carcinoma (≤ 20 mm). Abdom Radiol (NY). 2023. PMID: 36939913. doi:10.1007/s00261-023-03871-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。